Targets
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
1,518 genes, proteins and organisms that drugs act on, 1,211 of them human. Each page lists the drugs that hit it, how they act, and the diseases most associated with it.
- Targets: 1,518
- Human genes and proteins: 1,211
- With a US-approved drug page: 670
Most-Drugged Human Targets
Drugs with a US approval page acting on each.
How Drugs Act on Them
Each target's most common drug action. Click one to filter.
- 840
- 153
- 143
- 89
- 35
- 30
- 27
- 27
Every Target
Most drugs first1,518 targets
| Most associated disease | |||||
|---|---|---|---|---|---|
| DNA | Nucleic acid | Inhibitor | 99 | 51 | — |
| Tubulin | Complex group | Inhibitor | 80 | 15 | — |
| NR3C1Nuclear receptor subfamily 3 group C member 1 | Protein | Agonist | 75 | 46 | Glucocorticoid resistance |
| Bacterial penicillin-binding protein | Family | Inhibitor | 73 | 44 | — |
| EGFREpidermal growth factor receptor | Protein | Inhibitor | 70 | 11 | Non-small cell lung carcinoma |
| HRH1Histamine receptor H1 | Protein | Antagonist | 65 | 34 | Allergic rhinitis |
| GABA-A receptor; anion channel | Complex group | Positive allosteric modulator | 62 | 44 | — |
| DRD2Dopamine receptor D2 | Protein | Antagonist | 61 | 26 | Schizophrenia |
| Bacterial 70S ribosome | Protein nucleic-acid complex | Inhibitor | 57 | 26 | — |
| ADRB2Adrenoceptor beta 2 | Protein | Agonist | 52 | 21 | Asthma |
| Sodium channel alpha subunit | Family | Blocker | 52 | 37 | — |
| HTR2A5-hydroxytryptamine receptor 2A | Protein | Antagonist | 48 | 27 | Major depressive disorder |
| SLC6A2Solute carrier family 6 member 2 | Protein | Inhibitor | 48 | 25 | Attention deficit-hyperactivity disorder |
| PTGS1, PTGS2Cyclooxygenase | Family | Inhibitor | 47 | 17 | — |
| OPRM1Opioid receptor mu 1 | Protein | Agonist | 44 | 22 | Opiate dependence |
| ARAndrogen receptor | Protein | Agonist | 42 | 21 | Androgen insensitivity syndrome |
| CHRM3Cholinergic receptor muscarinic 3 | Protein | Antagonist | 42 | 24 | Prune belly syndrome |
| FLT1, FLT4, KDRVascular endothelial growth factor receptor | Family | Inhibitor | 40 | 9 | — |
| FLT3Fms related receptor tyrosine kinase 3 | Protein | Inhibitor | 39 | 8 | Acute myeloid leukemia |
| ERBB2Erb-b2 receptor tyrosine kinase 2 | Protein | Inhibitor | 38 | 5 | Non-small cell lung carcinoma |
| METMET proto-oncogene, receptor tyrosine kinase | Protein | Inhibitor | 37 | 6 | Papillary renal cell carcinoma |
| MAPK14Mitogen-activated protein kinase 14 | Protein | Inhibitor | 35 | 0 | Neurodegenerative disease |
| PGRProgesterone receptor | Protein | Agonist | 33 | 13 | Endometriosis |
| KDRKinase insert domain receptor | Protein | Inhibitor | 33 | 4 | Neoplasm |
| KITKIT proto-oncogene, receptor tyrosine kinase | Protein | Inhibitor | 32 | 11 | Gastrointestinal stromal tumor |
| CHRM1Cholinergic receptor muscarinic 1 | Protein | Antagonist | 32 | 18 | Parkinson disease |
| POLHuman immunodeficiency virus type 1 reverse transcriptase | Protein | Inhibitor | 31 | 15 | — |
| INSRInsulin receptor | Protein | Agonist | 30 | 6 | Donohue syndrome |
| PPARGPeroxisome proliferator activated receptor gamma | Protein | Agonist | 30 | 6 | Type 2 diabetes mellitus |
| SLC6A4Solute carrier family 6 member 4 | Protein | Inhibitor | 30 | 20 | Obsessive-compulsive disorder |
| ADRB1Adrenoceptor beta 1 | Protein | Antagonist | 28 | 19 | Hypertensive disorder |
| GYRA, GYRBBacterial DNA gyrase | Complex | Inhibitor | 27 | 12 | — |
| PI3-kinase class I | Complex group | Inhibitor | 26 | 1 | — |
| PDCD1Programmed cell death 1 | Protein | Inhibitor | 26 | 8 | Non-small cell lung carcinoma |
| MTORMechanistic target of rapamycin kinase | Protein | Inhibitor | 26 | 1 | Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome |
| HTR1A5-hydroxytryptamine receptor 1A | Protein | Agonist | 25 | 8 | Major depressive disorder |
| PDGFRA, PDGFRBPlatelet-derived growth factor receptor | Complex | Inhibitor | 25 | 6 | — |
| TOP1DNA topoisomerase I | Protein | Inhibitor | 24 | 4 | Small cell lung carcinoma |
| Phosphodiesterase 4 | Family | Inhibitor | 24 | 9 | — |
| Voltage-gated L-type calcium channel | Family | Blocker | 24 | 10 | — |
| ESR1Estrogen receptor 1 | Protein | Agonist | 23 | 12 | Breast cancer |
| ESR1, ESR2Estrogen receptor | Family | Modulator | 23 | 6 | — |
| HTR2C5-hydroxytryptamine receptor 2C | Protein | Antagonist | 22 | 14 | Autism |
| PPARAPeroxisome proliferator activated receptor alpha | Protein | Agonist | 21 | 5 | Type 2 diabetes mellitus |
| Glutamate [NMDA] receptor | Complex group | Antagonist | 20 | 6 | — |
| GNRHRGonadotropin releasing hormone receptor | Protein | Antagonist | 20 | 8 | Hypogonadotropic hypogonadism |
| IGF1RInsulin like growth factor 1 receptor | Protein | Inhibitor | 20 | 5 | Growth delay due to insulin-like growth factor I resistance |
| NS5BRNA-directed RNA polymerase | Protein | Inhibitor | 20 | 2 | — |
| SSpike glycoprotein | Protein | Inhibitor | 20 | 0 | — |
| ACHEAcetylcholinesterase (Yt blood group) | Protein | Inhibitor | 19 | 9 | Alzheimer disease |
Drugs, mechanisms and targets are from ChEMBL (EMBL-EBI, CC BY-SA 3.0), which records approved and clinical-stage drugs. Gene names, functions (from UniProt, CC BY 4.0) and disease associations are from the Open Targets Platform (CC0); an association score runs from 0 to 1 and combines genetic, literature, animal-model and drug evidence. Refreshed weekly, last Nov 17, 2026. ChEMBL and Open Targets